Sequencing analysis of OMI/HTRA2 shows previously reported pathogenic mutations in neurologically normal controls.
about
Parkinson's disease: from monogenic forms to genetic susceptibility factorsMitochondrial dynamics and mitophagy in Parkinson's disease: disordered cellular power plant becomes a big deal in a major movement disorderDrosophila HtrA2 is dispensable for apoptosis but acts downstream of PINK1 independently from ParkinGenetic susceptibility in Parkinson's diseaseLack of replication of association between GIGYF2 variants and Parkinson disease.Novel mitochondrial substrates of omi indicate a new regulatory role in neurodegenerative disorders.Caenorhabditis elegans: a model to investigate oxidative stress and metal dyshomeostasis in Parkinson's diseaseUnravelling the role of defective genes.The effectiveness of opioid substitution treatments for patients with opioid dependence: a systematic review and multiple treatment comparison protocol.Mitochondrial and Cell Death Mechanisms in Neurodegenerative Diseases.Modulation of mitochondrial function and morphology by interaction of Omi/HtrA2 with the mitochondrial fusion factor OPA1.Neural-specific deletion of Htra2 causes cerebellar neurodegeneration and defective processing of mitochondrial OPA1.Drosophila models of Parkinson's disease: discovering relevant pathways and novel therapeutic strategies.Mitochondrial serine protease HTRA2 p.G399S in a kindred with essential tremor and Parkinson disease.Phosphorylation of HtrA2 by cyclin-dependent kinase-5 is important for mitochondrial function.Novel variant Pro143Ala in HTRA2 contributes to Parkinson's disease by inducing hyperphosphorylation of HTRA2 protein in mitochondria.Altered enzymatic activity and allele frequency of OMI/HTRA2 in Alzheimer's diseaseMitochondrial dynamics and Parkinson's disease: focus on parkin.Biology of mitochondria in neurodegenerative diseases.A large-scale genetic association study to evaluate the contribution of Omi/HtrA2 (PARK13) to Parkinson's disease.Drosophila as a model to study mitochondrial dysfunction in Parkinson's disease.Genetic variation of Omi/HtrA2 and Parkinson's diseaseLoss-of-function analysis suggests that Omi/HtrA2 is not an essential component of the PINK1/PARKIN pathway in vivoMitochondrial biology and oxidative stress in Parkinson disease pathogenesis.Emerging pathways in genetic Parkinson's disease: autosomal-recessive genes in Parkinson's disease--a common pathway?Mitochondrial dynamics in Parkinson's disease.Genetic insights into sporadic Parkinson's disease pathogenesis.Genetics of Parkinson disease and essential tremorMutation Analysis of HTRA2 Gene in Chinese Familial Essential Tremor and Familial Parkinson's Disease.The PARL family of mitochondrial rhomboid proteases.Mitochondrial protein quality control in health and disease.Mitochondrial proteomics as a selective tool for unraveling Parkinson's disease pathogenesis.Mitochondria, calcium, and endoplasmic reticulum stress in Parkinson's disease.Mitochondrial quality control: a matter of life and death for neurons.Insights into mitochondrial quality control pathways and Parkinson's disease.Genetic basis of Parkinson's disease: inheritance, penetrance, and expression.Deficiency of HTRA2/Omi is associated with infantile neurodegeneration and 3-methylglutaconic aciduria.HTRA2 p.G399S in Parkinson disease, essential tremor, and tremulous cervical dystoniaEpigenetics in Parkinson's Disease.m-AAA proteases, mitochondrial calcium homeostasis and neurodegeneration.
P2860
Q22242870-D40B288D-9C9D-46D4-A6BC-5ED4FF03AC1DQ27001551-73173F43-C297-4AE8-999F-76C5220FB765Q28752238-B6EEBC23-C93F-4B8B-A227-FC34792D0F4FQ30435626-451D0C7E-62FB-4748-8E7C-278544757830Q30437358-2BEC91F8-0148-4AF5-85AE-1775AAC10BFFQ33504585-3AB221FF-C8B8-440E-92B7-FEC3E15D4D0DQ33658107-D0446E75-FE24-49C6-963E-90C344A68B00Q34201811-47B9C34B-4FAA-4A3D-8040-9A1712225659Q34226309-D67B12B0-4C3E-4BBA-A061-140C8E87DDDEQ34502221-93C3A509-9776-4E68-BFC0-491DA174AE72Q34713631-4AB1E697-5FB4-4C78-96CC-8DA80FE8FFF5Q34758274-EA2E12D5-7E6E-4A0E-B63A-E124BB8311A0Q34787767-EB55F765-FDC7-4B09-9BF0-E89D98A1A09FQ34792986-B23198AE-D98D-4C59-A96F-5C4637CFE9CBQ35315489-97E8DF6A-6CAF-4064-90C5-EFD3CC426F22Q35544534-330648E5-0798-43B8-AE03-4DCD94C2DF9BQ35585384-BD823E5B-DFBD-4A13-9962-CCDB1A8AB851Q35799161-643DCDAE-07C0-4274-B9F1-CB2C8D2CB60AQ36488715-C6074AC8-27D4-4AC1-A2D1-F80DA4600438Q36494703-626FE077-F391-4395-B2E3-5DC0871AC990Q36526622-23634D5A-BBEF-4CA3-B89B-AFBC4F612A40Q37037500-697A163C-ACAE-44FC-B94E-1E45F6EB0508Q37281615-CECDD793-9760-45DA-8D31-244806A32BC9Q37315448-BAF7C96D-00BF-4452-B6CA-F865CF1E68DEQ37330543-1D53ABEB-A93A-4DEF-967C-9809AE6985ABQ37364337-A6954DF1-4C00-4F05-BEFD-38E4C8A77CD1Q37583402-0A494F35-4E38-498B-86AC-0EC5B0CE730CQ37594762-FCDD81BF-B784-4ECA-A214-D074DF28A6C8Q37627534-22BC6F2B-AEF5-4E71-8B62-0F10937E1F3DQ37666154-CC5110BB-EECB-44D8-AAEF-A414452D64E1Q37686252-74FA18CE-CA54-43CD-9584-8B2CEB555594Q37727186-2062ED0D-DB2D-405B-953F-51AD5FCA986EQ37889815-DA168A90-C5C5-4F33-BC69-D0377A634C85Q37987023-2B07560E-710E-4C47-87A5-A0B7682DADCFQ38104226-E6F7EE15-7FFC-49C2-B64C-B9BEF1E4900DQ38115298-4D411C42-1818-4274-AB90-5CD783CE9433Q41924560-98AF6616-7CAB-4732-8B77-5FBE0CD20FC2Q42562233-552FFADA-8A60-4F03-9C59-CF8C39A32201Q47320399-5EBB908F-370C-4765-B3A3-0AB8041FFDC9Q49939367-D4027746-FE66-4577-9E6B-922D6E012522
P2860
Sequencing analysis of OMI/HTRA2 shows previously reported pathogenic mutations in neurologically normal controls.
description
2008 nî lūn-bûn
@nan
2008 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մարտին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Sequencing analysis of OMI/HTR ...... eurologically normal controls.
@ast
Sequencing analysis of OMI/HTR ...... eurologically normal controls.
@en
type
label
Sequencing analysis of OMI/HTR ...... eurologically normal controls.
@ast
Sequencing analysis of OMI/HTR ...... eurologically normal controls.
@en
prefLabel
Sequencing analysis of OMI/HTR ...... eurologically normal controls.
@ast
Sequencing analysis of OMI/HTR ...... eurologically normal controls.
@en
P2860
P356
P1476
Sequencing analysis of OMI/HTR ...... eurologically normal controls.
@en
P2093
Javier Simón-Sánchez
P2860
P304
P356
10.1093/HMG/DDN096
P577
2008-03-25T00:00:00Z